Lineage Cell Therapeutics In shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $12k | 11k | 1.09 |
| 2023-09-30 | $13k | 11k | 1.18 |
| 2023-06-30 | $15k | 11k | 1.41 |
| 2022-03-31 | $15k | 9.5k | 1.58 |
| 2021-12-31 | $23k | 9.5k | 2.42 |
| 2021-09-30 | $24k | 9.5k | 2.52 |
| 2021-06-30 | $27k | 9.5k | 2.84 |
| 2020-03-31 | $5.0k | 6.0k | 0.83 |
| 2019-12-31 | $5.0k | 6.0k | 0.83 |
| 2019-09-30 | $6.0k | 6.0k | 1.00 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors